Goebel A, Buhner S, Schedel R, Lochs H, Sprotte G Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology (Oxford). 2008 Aug;47(8):1223-7. doi: 10.1093/rheumatology/ken140. Epub 2008 Jun 7.
Griffin WS Inflammation and neurodegenerative diseases. Am J Clin Nutr. 2006 Feb;83(2):470S-474S. Review.
Guarner F Enteric flora in health and disease. Digestion. 2006;73 Suppl 1:5-12. Epub 2006 Feb 8. Review.
Hamer M, Molloy GJ Association of C-reactive protein and muscle strength in the English Longitudinal Study of Ageing. Age (Dordr). 2009 Sep;31(3):171-7. doi: 10.1007/s11357-009-9097-0. Epub 2009 May 23.
Lannergård A, Friman G, Ewald U, Lind L, Larsson A Serum amyloid A (SAA) protein and high-sensitivity C-reactive protein (hsCRP) in healthy newborn infants and healthy young through elderly adults. Acta Paediatr. 2005 Sep;94(9):1198-202.
Libby P, Okamoto Y, Rocha VZ, Folco E Inflammation in atherosclerosis: transition from theory to practice. Circ J. 2010 Feb;74(2):213-20. Epub 2010 Jan 9. Review.
Ordovas JM, Mooser V Metagenomics: the role of the microbiome in cardiovascular diseases. Curr Opin Lipidol. 2006 Apr;17(2):157-61. Review.
Puthoff ML, Janz KF, Nielson D The relationship between lower extremity strength and power to everday walking behaviors in older adults with functional limitations. J Geriatr Phys Ther. 2008;31(1):24-31.
Swidsinski A Standards for bacterial identification by fluorescence In situ hybridization within eukaryotic tissue using ribosomal rRNA-based probes. Inflamm Bowel Dis. 2006 Aug;12(8):824-6; author reply 826-7.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
